Tchem CHEK2 Serine/threonine-protein kinase Chk2

Protein Summary

Description

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest, activation of DNA repair and apoptosis in response to the presence of DNA double-strand breaks. May also negatively regulate cell cycle progression during unperturbed cell cycles. Following activation, phosphorylates numerous effectors preferentially at the consensus sequence [L-X-R-X-X-S/T]. Regulates cell cycle checkpoint arrest through phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their activity. Inhibition of CDC25 phosphatase activity leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. May also phosphorylate NEK6 which is involved in G2/M cell cycle arrest. Regulates DNA repair through phosphorylation of BRCA2, enhancing the association of RAD51 with chromatin which promotes DNA repair by homologous recombination. Also stimulates the transcription of genes involved in DNA repair (including BRCA2) through the phosphorylation and activation of the transcription factor FOXM1. Regulates apoptosis through the phosphorylation of p53/TP53, MDM4 and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may alleviate inhibition by MDM2, leading to accumulation of active p53/TP53. Phosphorylation of MDM4 may also reduce degradation of p53/TP53. Also controls the transcription of pro-apoptotic genes through phosphorylation of the transcription factor E2F1. Tumor suppressor, it may also have a DNA damage-independent function in mitotic spindle assembly by phosphorylating BRCA1. Its absence may be a cause of the chromosomal instability observed in some cancer cells. Promotes the CCAR2-SIRT1 association and is required for CCAR2-mediated SIRT1 inhibition (PubMed:25361978). In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Uniprot Accession IDs

• O96017
• A8K3Y9
• B7ZBF3
• B7ZBF4
• B7ZBF5
• Q6QA03
• Q6QA04
• Q6QA05
• Q6QA06
• Q6QA07
• Q6QA08
• Q6QA10
• Q6QA11
• Q6QA12
• Q6QA13
• Q9HBS5
• Q9HCQ8
• Q9UGF0
• Q9UGF1

Gene Name

• CHEK2

Ensembl ID

• ENST00000328354
• ENSP00000329178
• ENSG00000183765
• ENST00000348295
• ENSP00000329012
• ENST00000382580
• ENSP00000372023
• ENST00000402731
• ENSP00000384835
• ENST00000403642
• ENSP00000384919
• ENST00000404276
• ENSP00000385747
• ENST00000405598
• ENSP00000386087
• ENST00000417588
• ENSP00000412901
• ENST00000433728
• ENSP00000404400
• ENST00000448511
• ENSP00000404567
• ENST00000649563
• ENSP00000496928
• ENST00000650281
• ENSP00000497000

Symbol

• CDS1
• CHK2
• RAD53
• CDS1
• CHK2
• LFS2
• RAD53
• hCds1
• HuCds1
• PP1425

Knowledge Table

Most Knowledge About	Knowledge Value (0 to 1 scale)
biological term	1
kinase	0.99
molecular function	0.99
biological process	0.96
hub protein	0.95

Protein Classes

DTO Classes

Protein / Kinase / Protein Kinase / Camk Group / Rad53 Family / Serine/threonine-protein Kinase Chk2

IDG Development Level Summary

Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 1683.44   (req: < 5)

Gene RIFs: 479   (req: <= 3)

Antibodies: 1805   (req: <= 50)

Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 1683.44   (req: >= 5)

Gene RIFs: 479   (req: > 3)

Antibodies: 1805   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 40

Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligands: 148

Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 1